↓ Skip to main content

MART-1 peptide vaccination plus IMP321 (LAG-3Ig fusion protein) in patients receiving autologous PBMCs after lymphodepletion: results of a Phase I trial

Overview of attention for article published in Journal of Translational Medicine, April 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (67th percentile)
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

twitter
1 X user
patent
1 patent

Citations

dimensions_citation
69 Dimensions

Readers on

mendeley
73 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
MART-1 peptide vaccination plus IMP321 (LAG-3Ig fusion protein) in patients receiving autologous PBMCs after lymphodepletion: results of a Phase I trial
Published in
Journal of Translational Medicine, April 2014
DOI 10.1186/1479-5876-12-97
Pubmed ID
Authors

Emanuela Romano, Olivier Michielin, Verena Voelter, Julien Laurent, Hélène Bichat, Athina Stravodimou, Pedro Romero, Daniel E Speiser, Frédéric Triebel, Serge Leyvraz, Alexandre Harari

Abstract

Immunotherapy offers a promising novel approach for the treatment of cancer and both adoptive T-cell transfer and immune modulation lead to regression of advanced melanoma. However, the potential synergy between these two strategies remains unclear.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 73 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 1%
Unknown 72 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 16 22%
Student > Ph. D. Student 14 19%
Student > Master 7 10%
Other 5 7%
Student > Bachelor 5 7%
Other 10 14%
Unknown 16 22%
Readers by discipline Count As %
Agricultural and Biological Sciences 13 18%
Immunology and Microbiology 13 18%
Medicine and Dentistry 9 12%
Biochemistry, Genetics and Molecular Biology 8 11%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Other 8 11%
Unknown 20 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 December 2019.
All research outputs
#7,199,392
of 22,753,345 outputs
Outputs from Journal of Translational Medicine
#1,156
of 3,977 outputs
Outputs of similar age
#71,059
of 226,854 outputs
Outputs of similar age from Journal of Translational Medicine
#15
of 64 outputs
Altmetric has tracked 22,753,345 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 3,977 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.5. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 226,854 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 64 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.